Annual Current Liabilities
$4.51 M
-$9.26 M-67.23%
31 December 2023
Summary:
AcelRx Pharmaceuticals annual total current liabilities is currently $4.51 million, with the most recent change of -$9.26 million (-67.23%) on 31 December 2023. During the last 3 years, it has fallen by -$14.00 million (-75.62%).ACRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$4.51 M
+$938.00 K+26.25%
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly total current liabilities is currently $4.51 million, with the most recent change of +$938.00 thousand (+26.25%) on 31 December 2023.ACRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -75.6% | -75.6% |
| 5 y5 years | -66.8% | -66.8% |
ACRX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -75.6% | -78.5% |
AcelRx Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $4.51 M(-67.2%) | $4.51 M(+26.2%) |
| Sept 2023 | - | $3.57 M(-15.3%) |
| June 2023 | - | $4.22 M(-55.4%) |
| Mar 2023 | - | $9.46 M(-31.3%) |
| Dec 2022 | $13.77 M(-25.6%) | $13.77 M(-12.0%) |
| Sept 2022 | - | $15.65 M(-11.5%) |
| June 2022 | - | $17.69 M(+3.9%) |
| Mar 2022 | - | $17.03 M(-8.0%) |
| Dec 2021 | $18.51 M(+5.0%) | $18.51 M(+8.4%) |
| Sept 2021 | - | $17.07 M(+12.4%) |
| June 2021 | - | $15.19 M(-2.3%) |
| Mar 2021 | - | $15.54 M(-11.9%) |
| Dec 2020 | $17.64 M(+29.6%) | $17.64 M(+6.5%) |
| Sept 2020 | - | $16.56 M(+0.8%) |
| June 2020 | - | $16.43 M(+4.5%) |
| Mar 2020 | - | $15.72 M(+15.5%) |
| Dec 2019 | $13.61 M(-14.5%) | $13.61 M(+19.1%) |
| Sept 2019 | - | $11.43 M(+38.0%) |
| June 2019 | - | $8.29 M(-56.3%) |
| Mar 2019 | - | $18.95 M(+18.9%) |
| Dec 2018 | $15.93 M(+16.6%) | $15.93 M(+10.1%) |
| Sept 2018 | - | $14.47 M(+9.5%) |
| June 2018 | - | $13.21 M(-0.3%) |
| Mar 2018 | - | $13.25 M(-3.0%) |
| Dec 2017 | $13.66 M(+34.0%) | $13.66 M(-8.1%) |
| Sept 2017 | - | $14.87 M(+9.7%) |
| June 2017 | - | $13.56 M(+6.3%) |
| Mar 2017 | - | $12.75 M(+25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $10.19 M(-20.3%) | $10.19 M(-34.4%) |
| Sept 2016 | - | $15.53 M(-26.1%) |
| June 2016 | - | $21.03 M(+25.1%) |
| Mar 2016 | - | $16.80 M(+31.5%) |
| Dec 2015 | $12.78 M(-6.9%) | $12.78 M(+62.1%) |
| Sept 2015 | - | $7.88 M(-40.7%) |
| June 2015 | - | $13.31 M(-13.4%) |
| Mar 2015 | - | $15.36 M(+11.9%) |
| Dec 2014 | $13.73 M(+99.9%) | $13.73 M(+32.4%) |
| Sept 2014 | - | $10.37 M(+18.6%) |
| June 2014 | - | $8.74 M(+89.7%) |
| Mar 2014 | - | $4.61 M(-32.9%) |
| Dec 2013 | $6.87 M(-52.1%) | $6.87 M(-44.7%) |
| Sept 2013 | - | $12.43 M(+2.5%) |
| June 2013 | - | $12.12 M(-19.1%) |
| Mar 2013 | - | $14.98 M(+4.5%) |
| Dec 2012 | $14.33 M(+82.7%) | $14.33 M(+17.2%) |
| Sept 2012 | - | $12.23 M(+14.3%) |
| June 2012 | - | $10.69 M(+19.5%) |
| Mar 2012 | - | $8.95 M(+14.1%) |
| Dec 2011 | $7.84 M(-41.5%) | $7.84 M(+54.0%) |
| Sept 2011 | - | $5.09 M(+34.9%) |
| June 2011 | - | $3.78 M(-34.9%) |
| Mar 2011 | - | $5.80 M(-56.7%) |
| Dec 2010 | $13.41 M(+123.1%) | $13.41 M(+127.5%) |
| Sept 2010 | - | $5.90 M(-1.9%) |
| Dec 2009 | $6.01 M(+32.7%) | $6.01 M |
| Dec 2008 | $4.53 M | - |
FAQ
- What is AcelRx Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for AcelRx Pharmaceuticals?
What is AcelRx Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ACRX is $4.51 M
What is the all time high annual current liabilities for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual total current liabilities is $18.51 M
What is AcelRx Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ACRX is $4.51 M
What is the all time high quarterly current liabilities for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly total current liabilities is $21.03 M